Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
BioCule logo — company profile

BioCule

Founded 2001 Iceland Iceland 2 employees Grant Total: $78.07M Biotechnology, Health Care

General Information

Company Name BioCule
Founded Year 2001
Location Iceland Iceland +2
Employees 2
Industries Biotechnology, Health Care
Funding Stage Grant
Social

Get notified when BioCule moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About BioCule

BioCule is a biotechnology startup based in Iceland that specializes in revolutionizing the analysis of complex nucleic acid samples. The company was founded in 2001 and has received a ISK4.77M grant investment from the Technology Development Fund in March 2016. BioCule offers a one- and two-dimensional nucleic acid microelectrophoresis system that utilizes single-use precast gel cassettes. This system allows for size distribution and relative amount detection of various nucleic acid components including double-stranded DNA, single-stranded DNA, RNA*DNA hybrids, crosslinked DNA, damaged DNA, and DNA repair. The technology caters to diverse applications such as complex PCR, cDNA synthesis, CHIP-sequencing DNA, NGS sample preparation, and the detection of DNA damage in vivo or in biobank samples. Additionally, the company provides 1-D PAGE electrophoresis in just 10 minutes, thus offering efficient and comprehensive nucleic acid analysis. BioCule's innovation addresses critical needs in the biotechnology and healthcare industries, where accurate and efficient nucleic acid analysis is crucial for various research and diagnostic purposes. Overall, BioCule presents an intriguing opportunity for investment, given its innovative approach to nucleic acid analysis and its potential to make significant contributions to the biotechnology and healthcare sectors.

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
01 Mar 2016
Grant •••••• 1
Investor
15 Dec 2014
Grant •••••• 1
Investor
01 Mar 2014
Grant •••••• 1
Investor
01 Mar 2013
Grant •••••• 1
Investor
01 Mar 2012

View All 7 Funding Rounds

BioCule Alternatives & Competitors

BioCule vs
Hunan Runmei Gene Technology
Hunan Runmei Gene Technology China

Single-use samplers, RT-PCR method, antibody detection kit, virus extraction and detection kit

3 employees
Health Care, Manufacturing
BioCule vs
Cranebio Co.,Ltd
Cranebio Co.,Ltd Japan

New concept wearable feminine testers and infectious disease self-testing kits based on the DNA orig...

Series A
2 employees
Health Care
BioCule vs
Quantapore
Quantapore

Experience unprecedented speed and cost-efficiency with our innovative nanopore-based sequencing tec...

Series C
Biotechnology, Health Care

FAQ About BioCule

BioCule - The Nucleic Acid Quality Company BioCule is revolutionizing the way complex nucleic acid samples are analysed. THE ONE- AND TWO-DIMENSIONAL NUCLEIC ACID MICROELECTROPHORESIS SYSTEM FROM BIOCULE Single Use Precast Gel Cassettes Size distribution and relative amount detection...
BioCule was founded in 2001.
BioCule is headquartered in Iceland.
BioCule operates in the following industries: Biotechnology, Health Care.
BioCule has approximately 2 employees.
BioCule has completed 7 funding rounds, raising a total of $78.07M. The latest funding stage is Grant.
Top alternatives and competitors to BioCule include Hunan Runmei Gene Technology, Cranebio Co.,Ltd, Quantapore, Diffinity Genomics, Jiaohong Biology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
BioCule and Hunan Runmei Gene Technology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors BioCule and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes